Clinical & Experimental Metastasis

, Volume 3, Issue 2, pp 77–86 | Cite as

Expression ofabl and other oncogenes is independent of metastatic potential in Abelson virus-transformed malignant murine large cell lymphoma

  • Varda Rotter
  • David Wolf
  • Mark Blick
  • Garth L. Nicolson


The role of oncogene expression in tumor metastasis was examined using the Abelson leukemia virus-transformed murine large cell lymphoma RAW117. Cell sublines of low and high metastatic potential expressed equallyabl oncogene-coded mRNA and its phosphoprotein product p160, and the capacity of p160 to become autophosphorylated withγ-[32P]ATP was the same among low and high metastatic cells. The expression of other oncogene-coded mRNAs (fos, myc, myb), if present, was also similar in low and high metastatic RAW117 cells. Although oncogene expression is thought to be important in initiating, and in some cases maintaining, the transformed phenotype, its expression in RAW117 lymphoma cells appears to be unrelated to metastatic phenotype.


Public Health Lymphoma Leukemia Cancer Research Cell Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Albino, A. P., LeStrange, R., Oliff, A. I., Furth, M. E., andOld L. J., 1984, Transformingras genes from human melanoma: A manifestation of tumor heterogeneity?Nature,308, 69–72.Google Scholar
  2. [2]
    Alitalo, K., Schwab, M., Lin, C. C., Varmus, H. E., andBishop, J. M., 1983, Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma.Proceedings of the National Academy of Sciences, U.S.A.,80, 1707–1711.Google Scholar
  3. [3]
    Auffray, D., andRougeon, F., 1980, Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor RNA.European Journal of Biochemistry,107, 303–314.Google Scholar
  4. [4]
    Aviv, H., andLeder, P., 1972, Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid cellulose.Proceedings of the National Academy of Sciences, U.S.A.,69, 1408–1412.Google Scholar
  5. [5]
    Blair, D. G., Oskarsson, M., Wood, T. G., McClements, W. L., Fischinger, P. J., andVan De Woude, G., 1981, Activation of the transforming potential of anormal cell sequence: A molecular model for oncogenesis.Science,212, 941–943.Google Scholar
  6. [6]
    Brunson, K. W., andNicolson, G. L., 1978, Selection and biologic properties of malignant variants of a murine lymphosarcoma.Journal of the National Cancer Institute,61, 1499–1503.Google Scholar
  7. [7]
    Chaganti, R. S. K., 1983, The significance of chromosome change to neoplastic development.Chromosome Mutation and Neoplasia, edited by J. German (New York: Liss), pp. 359–396.Google Scholar
  8. [8]
    Chen, T. R., 1977,In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.Experimental Cell Research,104, 255–262.Google Scholar
  9. [9]
    Collet, M. S., andErikson, R. L., 1978, Protein kinase activity associated with the avian sarcoma virus Src gene product.Proceedings of the National Academy of Sciences, U.S.A.,75, 2012–2024.Google Scholar
  10. [10]
    Cooper, G. M., 1982, Cellular transforming genes.Science,218, 801–806.Google Scholar
  11. [11]
    Curran, T., Petters, G., van Bevoren, C., Teich, N. M., andVerma, I. M., 1982, FBJ murine osteosarcoma virus: Identification and molecular cloning of biologically active proviral DNA.Journal of Virology,44, 674–682.Google Scholar
  12. [12]
    Dalla-Favera, R., Martinotti, S., Gallo, R. C., Erikson, J., andCroce, C. M., 1983, Translocation and rearrangements of thec-myc oncogenes locus in human undifferentiated B-cell lymphomas.Science,219, 963–967.Google Scholar
  13. [13]
    Dalla-Favera, R.,Wong-Staal, F., andGallo, R. C., 1982, Oncogene amplication in promyelocytic leukemia cell line HL-60 and primary leukaemic cells of the same patient.Nature,298, 61–63.Google Scholar
  14. [14]
    DeFeo, D., Gonda, M. A., Young, H. A., Chang, E. H., Lowy, D. R., Scolnick, E. L. M., andEllis, R. W., 1981, Analysis of divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus.Proceedings of the National Academy of Sciences, U.S.A.,78, 3328–3332.Google Scholar
  15. [15]
    Denhardt, D., 1966, A membrane-filter technique for the detection of complementary DNA.Biophysical and Biochemical Research Communication,23, 641–646.Google Scholar
  16. [16]
    Der, C. J., Krontiris, T. G., andCooper, G. M., 1982, Transforming genes of human bladder and lung carcinoma cell lines are homologous to theras genes of Harvey and Kisten sarcoma viruses.Proceedings of the National Academy of Sciences, U.S.A.,79, 3637–3640.Google Scholar
  17. [17]
    Diamond, A., Devine, J. M., andCooper, G. M., 1983, Nucleotide sequence of a humanB-lym transforming gene activated in Burkitt's lymphoma.Science,225, 516–519.Google Scholar
  18. [18]
    Erikson, J., Ar-Rushdi, A., Drwinga, H. L., Nowell, P. C., andCroce, C. M., 1983, Transcriptional activation of the translocatedc-myc oncogenes in Burkitt lymphoma.Proceedings of the National Academy of Sciences, U.S.A.,80, 820–824.Google Scholar
  19. [19]
    Fidler, I. J., andHart, I. R., 1982, Biological diversity in metastatic neoplasms origins and implications.Science,217, 998–1003.Google Scholar
  20. [20]
    Franchini, G., Wong-Staal, F., Baluda, M. A., Lengel, C., andTronick, S. R., 1983, Structural organization and expression of human DNA sequences related to the transforming gene of avian myeloblastosis virus.Proceedings of the National Academy of Sciences, U.S.A.,80, 7385–7389.Google Scholar
  21. [21]
    Gallick, G. E., Kurzrock, R., Kloetzer, W. S., Arlinghaus, R. B., andGutterman, J. U., 1985, Expression of the p21 ras gene products in fresh primary and metastatic human colorectal tumors.Proceedings of the National Academy of Sciences, U.S.A.,82, 1795–1799.Google Scholar
  22. [22]
    Glisin, W., Crkvenjakov, R., andByus, C., 1974, Ribonucleic acid isolated by cesium chloride centrifugation.Biochemistry,13, 2633–2637.Google Scholar
  23. [23]
    Grunwald, D. J., Dale, B., Dudley, J., Lamph, W., Sugden, B., Ozanne, B., andKisser, R., 1982, Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells.Journal of Virology,43, 92–103.Google Scholar
  24. [24]
    Hayward, W. S., Neel, B. G., andAstrin, S. M., 1981, Activation of a cellularone gene by promoter insertion in ALV-induced lymphoid leukosis.Nature,290, 475–480.Google Scholar
  25. [25]
    Heisterkamp, N., Stephenson, J. R., Groffen, J., Hansen, P. F., Deklein, A., Bartram, C. T., andGrosveld, G., 1983, Localization of thec-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia.Nature,306, 239–242.Google Scholar
  26. [26]
    Kessler, S. W., 1975, Rapid isolation of antigens from cells with a staphylococcal protein A antibody adsorbent: Parameters of the interaction of antibody-antigen complex with protein A.Journal of Immunology,115, 1617–1624.Google Scholar
  27. [27]
    Kris, R. M., Avivi, A., Bar-Eli, M., Alon, Y., Carni, P. J., andRaz, A., 1985, The expression ofKI-RAS oncogene in tumor cell variants exhibiting different metastatic capabilities.International Journal of Cancer,35, 227–230.Google Scholar
  28. [28]
    Lane, M. A., Neary, D., andCooper, G. M., 1982, Activation of a cellular transforming gene in tumours induced by Abelson murine leukemia virus.Nature,300, 659–660.Google Scholar
  29. [29]
    Lait, S. A., Goff, S. P., Tabin, C. J., Paskind, M., Wang, J. Y. J., andBaltimore, D., 1983, Cloning and analysis of reverse transcript p160 genomes of Abelson murine leukemia virus.Journal of Virology,45, 1195–1199.Google Scholar
  30. [30]
    Laemmli, U. K., 1970, Cleavageof structural proteins during the assembly of the head of bacteriophage T4.Nature,227, 680–685.Google Scholar
  31. [31]
    McGuire, E. J., Mascali, J. J., Grady, S. R., andNicolson, G. L., 1984, Involvement of cell-cell adhesion molecules in liver colonization by metastatic murine lymphoma/lymphosarcoma variants.Clinical and Experimental Metastasis,2, 213–222.Google Scholar
  32. [32]
    Miner, K. M., andNicolson, G. L., 1983, Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma cells to macrophage-mediated cytolysis and/or cytostasis.Cancer Research,43, 2063–2071.Google Scholar
  33. [33]
    Miner, K. M., Walter, H., andNicolson, G. L., 1981, Subfractionation of malignant variants of metastatic murine lymphosarcoma cells by countercurrent distribution in two-polymer aqueous phases.Biochemistry,20, 6244–6250.Google Scholar
  34. [34]
    Nicolson, G. L., 1982, Cancer metastasis: Organ colonization and the cell surface properties of malignant cells.Biochimica et Biophysica Acta,695, 113–176.Google Scholar
  35. [35]
    Nicolson, G. L., 1984, Cell surface molecules and tumor metastasis. Regulation of metastatic diversity.Experimental Cell Research,150, 3–22.Google Scholar
  36. [36]
    Nicolson, G. L., 1984, Generation of phenotypic diversity and progression in metastatic tumors.Cancer Metastasis Review,3, 25–42.Google Scholar
  37. [37]
    Nicolson, G. L., 1984, Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity.Clinical and Experimental Metastasis,2, 85–105.Google Scholar
  38. [38]
    Nicolson, G. L., andPoste, G., 1982, Tumor cell diversity and host responses in cancer metastasis. I. Properties of metastatic cells.Current Problems in Cancer,7(6), 1–83.Google Scholar
  39. [39]
    Nicolson, G. L., andPoste, G., 1983, Tumor cell diversity and host responses in cancer metastasis. II. Host immune responses and therapy of metastases.Current Problems in Cancer,7(7), 1–43.Google Scholar
  40. [40]
    Nicolson, G. L., andPoste, G., 1983, Tumor implantation and invasion at metastatic sites.International Review of Experimental Pathology,25, 77–181.Google Scholar
  41. [41]
    Nicolson, G. L., Mascali, J. J., andMcGuire, E. J., 1982, Metastatic RAW117 lymphosarcoma as a model for malignant-normal cell interactions, Possible roles for cell surface antigens in determining the quantity and location of secondary tumors.Oncodevelopmental Biology and Medicine,4, 149–159.Google Scholar
  42. [42]
    Nicolson, G. L., Reaing, C. L., andBrunson, K. W., 1980, Blood-borne tumor metastasis: Some properties of selected tumor cell variants of differing malignancies.Tumor Progression, edited by R. G. Crispen (Amsterdam: Elsevier/North Holland), pp. 31–48.Google Scholar
  43. [43]
    Nowell, P. C., 1983, Tumor progression and clonal evolution: the role of genetic instability.In: J. German (ed.),Chromosome Mutation and Neoplasia, edited by J. German) (New York: Liss), pp. 413–432.Google Scholar
  44. [44]
    Poste, G., 1982, Experimental systems for analysis of the malignant phenotype.Cancer Metastasis Reviezvs,1, 141–199.Google Scholar
  45. [45]
    Poste, G., andFidler, I. J., 1980, The pathogenesis of cancer metastasis.Nature,283, 139–146.Google Scholar
  46. [46]
    Raschke, W. C., Ralph, P., Watson, J., Sklar, M., andCoon, H., 1975, Oncogenic transformation of murine lymphoid cells byin vitro infection with Abelson leukemia virus.Journal of the National Cancer Institute,54, 1249–1253.Google Scholar
  47. [47]
    Reading, C. L., Belloni, P. N., andNicolson, G. L., 1980, Selection andin vivo properties of lectin-attachment variants of malignant murine lymphosarcoma cell lines.Journal of the National Cancer Institute,64, 1241–1249.Google Scholar
  48. [48]
    Reading, C. L., Brunson, K. W., Torraini, M., andNicolson, G. L., 1980, Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70.Proceedings of the National Academy of Sciences, U.S.A.,77, 5943–5947.Google Scholar
  49. [49]
    Reading, C. L., Kraemer, P. M., Miner, K. M., andNicolson, G. L., 1983,In vivo andin vitro properties of malignant variants of RAW117 metastatic murine lymphr oma/lymphosacoma.Clinical and Experimental Metastasis,1, 135–151.Google Scholar
  50. [50]
    Reynolds, F. H., Sacks, T. I., Deobaghar, D. H., andStephenson, J. R., 1978, Cells nonproductively transformed by Abelson-Murine Leukemia Virus express a high molecular weight polyprotein containing structural and nonstructural components.Proceedings of the National Academy of Sciences, U.S.A.,75, 3974–3978.Google Scholar
  51. [51]
    Rigby, P. W., Dieckmann, M., Rhodes, C., andBerg, P., 1977, Labeling deoxyribonucleic acid to high specific activityin vitro by nick translation with DNA polymerase I.Journal of Molecular Biology,113, 237–251.Google Scholar
  52. [52]
    Rosenberg, N., andWitte, O. N., 1980, Abelson murine leukemia virus mutants with alteration in the virus specific p120 molecule.Journal of Virology,33, 340–348.Google Scholar
  53. [53]
    Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., andBarbacid, M., 1982, T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.Nature,298, 343–347.Google Scholar
  54. [54]
    Thomas, P. S., 1980, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences, U.S.A.,77, 5201–5205.Google Scholar
  55. [55]
    Thorgeirsson, U. P., Turpeenniemi-Hujanen, T., Williams, J. E., Westein, E. H., Heilman, C. A., Talmadge, J. E., andLiotta, L. A., 1985, NIH/3T3 cells transfected with human tumor DNA containing activatedras oncogenes express the metastatic phenotype in nude mice.Molecular and Cellular Biology,5, 259–262.Google Scholar
  56. [56]
    Wang, J. Y. J., andBaltimore, D., 1983, Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: Expression and relationship to the viral sequence.Molecular and Cellular Biology,3, 773–779.Google Scholar
  57. [57]
    Whitlock, C. A., Ziegler, S. F., andWitte, O. N., 1983, Progression of the transformed phenotype in clonal lines of Abelson virus infected lymphocytes.Molecular Cellular Biology,3, 596–604.Google Scholar
  58. [58]
    Witte, O. N., Rosenberg, N., Paskind, M., Shields, A., andBaltimore, D., 1978, Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells.Proceedings of the National Academy of Sciences, U.S.A.,75, 2488–2492.Google Scholar
  59. [59]
    Witte, O. N., Rosenberg, N., andBaltimore, D., 1979, Preparation of syngeneic tumor regressor serum reactive with the unique determinats of the Abelson murine leukemia virus-encoded p120 protein at the cell surface.Journal of Virology,31, 776–784.Google Scholar
  60. [60]
    Witte, O. N., Dasgupta, A., andBaltimore, D., 1980, Abelson murine leukemia virus protein is phosphorylatedin vitro to form phosphotyrosine.Nature,283, 826–831.Google Scholar

Copyright information

© Taylor & Francis Ltd 1985

Authors and Affiliations

  • Varda Rotter
    • 1
  • David Wolf
    • 1
  • Mark Blick
    • 2
  • Garth L. Nicolson
    • 3
  1. 1.Department of Cell BiologyThe Weizmann Institute of ScienceRehovotIsrael
  2. 2.Department of Clinical Immunology and Biological TherapyThe University of Texas M. D. Anderson Hospital and Tumor InstituteHoustonUSA
  3. 3.Department of Tumor BiologyThe University of Texas M. D. Anderson Hospital and Tumor InstituteHoustonUSA

Personalised recommendations